Potential of longitudinal data from single site and multi-center clinical trials for AI-research

Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Related Resources

Related Resources

A picture of a cancer patient on a couch, with two infusion bags in the foreground

Optimizing Clinical Trials without Compromising Patient Care: An Investigational Site’s Perspective

Attracting and retaining industry-sponsored clinical trials can be quite appealing for healthcare institutions. Besides obvious financial and…

A picture of a cancer patient talking to the doctor who is treating her.

Closing the Care Gap by Shaping the Future of Evidence-Based Medicine

Healthcare still lags behind other economic sectors in terms of digitalization. Despite significant advancements in diagnostic and therapeutic…

Three Key Benefits of Structured Reporting in Daily Clinical Routine

In this short interview, Dr. Remy Geenen from Northwest Clinics in Alkmaar, Netherlands, shares his personal mint Lesion™ experience, where he talks…